Menu Search
Equities

Inspire Medical Systems Inc

2DR:BER

Inspire Medical Systems Inc

Actions
  • Price (EUR)181.50
  • Today's Change3.90 / 2.20%
  • Shares traded--
  • 1 Year change+37.50%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 15:16 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Inspire Medical Systems Inc grew revenues 53.19% from 407.86m to 624.80m while net income improved from a loss of 44.88m to a smaller loss of 21.15m.
Gross margin84.77%
Net profit margin4.37%
Operating margin1.79%
Return on assets4.60%
Return on equity5.33%
Return on investment5.12%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Inspire Medical Systems Inc fell by 256.06m. However, the company earned 24.65m from its operations for a Cash Flow Margin of 3.95%. In addition the company generated 13.95m cash from financing while 294.82m was spent on investing.
Cash flow per share1.26
Price/Cash flow per share146.81
Book value per share23.25
Tangible book value per share23.25
More ▼

Balance sheet in USDView more

Inspire Medical Systems Inc has little financial risk as the capital structure does not rely on leverage.
Current ratio7.84
Quick ratio6.94
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.